West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Surgical & Medical Instruments & Apparatus · Exton, PA · filing with the SEC since 1994

Full chart Alerts Compare

Grade5.7

◀ Past 6.3● Present 6.3▶ Future 4.3

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2025, as filed

Revenue$3.07B+6.3%

Net income$494M+0.2%

Earnings per share$6.79+1.5%

Operating cash flow$755M+15.5%

Cash$791M+63.3%

Debt$203M+0.1%

Shareholders’ equity$3.18B+18.4%

Shares, diluted72.7M-1.4%

Return on equity15.5%

The recordfrom its filings

Filings in 202662

Newest filingNov 5 · SCHEDULE 13G/A

Annual reportFeb 17, 2026

Quarterly reportOct 29, 2026

Next report due10-K by Mar 1

Insider sales, 12 months$6.6M

Insider buys, 12 months$0.00

Patents granted262

Filer categoryLarge accelerated filer

Trailing twelve months to Sep 2026Revenue $3.40BNet income $639MCash from operations $655Mthe four newest filed quarters added

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

09101819202122232425

As filed, in USD. Nothing here is a forecast.

News

Nov 5, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Oct 29, 2026 · SEC EDGAR · Form 10-Q

Quarterly report

Open the filing on sec.gov

Oct 29, 2026 · SEC EDGAR · Form 8-K

Results released

Open the filing on sec.gov

Oct 26, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Oct 2, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 15, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 10, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 10, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 10, 2026 · SEC EDGAR · Form 3

Insider holding, initial

Open the filing on sec.gov

Aug 12, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

West Pharmaceutical Services, Inc. is classed by the SEC under Surgical & Medical Instruments & Apparatus (industry code 3841), based in Exton, PA. Proprietary Products was 81% of fiscal 2025 revenue.

Newest on the record

Large holder update, amended on Nov 5. Before it, quarterly report on Oct 29.

What is due next

The 10-K for the period to Dec 31, 2026, due by Mar 1, 2027.

About WST

West Pharmaceutical Services, Inc. is classed by the SEC under Surgical & Medical Instruments & Apparatus (industry code 3841), based in Exton, PA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $3.1 billion and a profit of $494 million (its filed statements).

IndustrySurgical & Medical Instruments & Apparatus

HeadquartersExton, PA

Business modelProduct business

ExchangeNYSE

Filing since1994

Fiscal year endsDec 31

SEC number (CIK)105770

Peers on fileICUI, MMED, IART, GMED

Who runs it

Financial performance

In fiscal 2025 West Pharmaceutical Services’s revenue was $3.07 billion, up 6.3% from $2.89 billion the year before. Net income was $493.7 million, up 0.2%.

Annual report, filed Feb 17, 2026.

Financial statements

The grade

West Pharmaceutical Services grades 5.7 of 10 against its own industry, the 121 companies in Surgical & Medical Instruments & Apparatus. All nine metrics are read as filed.

◀ Past6.3

● Present6.3

▶ Future4.3

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton WST · research, not advice